Keyphrases
Systemic Effects
100%
Asthmatic children
100%
Budesonide
100%
Nebulized Budesonide
100%
Suspension Formulation
100%
Airway Effects
100%
Pulmicort Respules
80%
Captisol
80%
Confidence Interval
60%
Fractional Exhaled Nitric Oxide (FeNO)
60%
Twice Daily
40%
Urinary Cortisol
40%
Nebulizer
40%
Creatinine Ratio
40%
Allergy
20%
Asthma
20%
Moderate to Severe
20%
Lung Function
20%
Persistent Asthma
20%
Adrenal Suppression
20%
Bioactivity
20%
Anti-inflammatory Activity
20%
Dose Ratio
20%
Nominal Dose
20%
Budesonide Suspension
20%
Cyclodextrin
20%
E-flows
20%
Microgram
20%
Medicine and Dentistry
Nebulized Budesonide
100%
Budesonide
100%
Beta Cyclodextrin Sulfobutyl Ether
40%
Nitric Oxide
30%
Urinary System
20%
Hydrocortisone
20%
Creatinine
20%
Nebulizer
20%
Adrenal Suppression
10%
Allergic Asthma
10%
Antiinflammatory Activity
10%
Moderate Persistent Asthma
10%
Cyclodextrin
10%
Lung
10%
Biological Activity
10%
Immunology and Microbiology
Budesonide
100%
Airway
100%
Solution and Solubility
45%
Exhaled Nitric Oxide
27%
Nebulization
27%
Hydrocortisone Urine Level
18%
Adrenal Suppression
9%
Antiinflammatory Activity
9%
Allergic Asthma
9%
Moderate Persistent Asthma
9%
Dose Ratio
9%
Biological Activity
9%
Pharmacology, Toxicology and Pharmaceutical Science
Budesonide
100%
Nebulized Budesonide
100%
Beta Cyclodextrin Sulfobutyl Ether
40%
Nitric Oxide
30%
Hydrocortisone
20%
Creatinine
20%
Nebulizer
20%
Anti-Inflammatory Drug
10%
Allergic Asthma
10%
Cyclodextrin
10%
Moderate Persistent Asthma
10%
Agricultural and Biological Sciences
Budesonide
100%
Confidence Interval
27%
Cortisol
18%
Urinary System
18%
Creatinine
18%
Cross-over Studies
9%
Anti-Inflammatory Activity
9%
Lung
9%
Cyclodextrin
9%